Rankings
▼
Calendar
TEVA Q3 2022 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$37B
Q3 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$3.6B
-7.5% YoY
Gross Profit
$1.7B
46.4% margin
Operating Income
$419M
11.7% margin
Net Income
$56M
1.6% margin
EPS (Diluted)
$0.05
QoQ Revenue Growth
-5.0%
Cash Flow
Operating Cash Flow
$543M
Free Cash Flow
$421M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$44.3B
Total Liabilities
$34.7B
Stockholders' Equity
$8.8B
Cash & Equivalents
$2.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.6B
$3.9B
-7.5%
Gross Profit
$1.7B
$1.8B
-7.0%
Operating Income
$419M
$623M
-32.7%
Net Income
$56M
$292M
-80.8%
Revenue Segments
Product
$3.0B
84%
Distribution Service
$383M
11%
Product and Service, Other
$139M
4%
License
$52M
1%
Geographic Segments
North America Segment
$1.8B
54%
Europe Segment
$1.1B
32%
International Markets
$475M
14%
← FY 2022
All Quarters
Q4 2022 →